[1]
Negro, F. and Maistat, L. 2017. Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over. Swiss Medical Weekly. 147, 4950 (Dec. 2017), w14570. DOI:https://doi.org/10.4414/smw.2017.14570.